These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23173870)

  • 1. Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.
    Wang S; Xue S; Dai Y; Yang J; Chen Z; Fang X; Zhou W; Wu W; Li Q
    Diagn Pathol; 2012 Nov; 7():159. PubMed ID: 23173870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
    Wang S; Li Q; Wang K; Dai Y; Yang J; Xue S; Han F; Zhang Q; Liu J; Wu W
    Clin Transl Oncol; 2013 Oct; 15(10):849-54. PubMed ID: 23408039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
    Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy.
    Sun X; Liu Z; Yang Z; Xiao L; Wang F; He Y; Su P; Wang J; Jing B
    Diagn Pathol; 2013 Dec; 8():208. PubMed ID: 24350576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder.
    Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K
    Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
    Tang K; Wang C; Chen Z; Xu H; Ye Z
    Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
    Yang Y; Song KL; Chang H; Chen L
    Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
    Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deregulation of miR-133b is associated with poor prognosis in bladder cancer.
    Shi Z; Kadeer A; Wang M; Wen B; Li M; Huang J; Gao Y; Liu E; Liu D; Jia D; Liang C
    Pathol Res Pract; 2019 Feb; 215(2):354-357. PubMed ID: 30591241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Meng FM; Meng FM; Song XL
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of microRNA-372 upregulation with poor prognosis in human glioma.
    Li G; Zhang Z; Tu Y; Jin T; Liang H; Cui G; He S; Gao G
    Diagn Pathol; 2013 Jan; 8():1. PubMed ID: 23298385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of miR-222 is associated with poor prognosis in bladder cancer.
    Zhang DQ; Zhou CK; Jiang XW; Chen J; Shi BK
    World J Surg Oncol; 2014 Jul; 12():241. PubMed ID: 25078265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
    Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
    Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
    Ma L; Xu Z; Xu C; Jiang X
    Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of microRNA-497 and its prognostic significance in human breast cancer.
    Wang S; Li H; Wang J; Wang D
    Diagn Pathol; 2013 Oct; 8():172. PubMed ID: 24143964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
    Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
    Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
    World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.